Elpida Therapeutics will host an open virtual meeting via Zoom on Thursday, January 18, from 3-4 p.m. EST, to provide an update on the ongoing gene therapy trial for treating CLN7 Batten disease, which has been led by the University of Texas Southwestern Medical Center.
They will discuss their plans to expand the treatment to more patients in the future, and how our patient community can help move this program forward. Please note that this meeting is primarily for families affected by CLN7 disease but is open to all Batten families, researchers, clinicians, patient advocacy groups, etc. who wish to attend.
Join the Zoom meeting by clicking the link below.
Link: https://us02web.zoom.us/j/9890666291?omn=87196549060
Meeting ID: 989 066 6291
